GoodRx
(NASDAQ) GDRX
GoodRx Financials at a Glance
Market Cap
$698.85M
Revenue (TTM)
$796.85M
Net Income (TTM)
$30.44M
EPS (TTM)
$0.08
P/E Ratio
24.23
Dividend
$0.00
Beta (Volatility)
1.75 (High)
Dividend
$0.00
Beta (Volatility)
1.75 (High)
Price
$2.06
Volume
1,349,123.966
Open
$2.08
Price
$2.06
Volume
1,349,123.966
Open
$2.08
Previous Close
$2.06
Daily Range
$2.03 - $2.10
52-Week Range
$1.77 - $5.81
Dividend
$0.00
Beta (Volatility)
1.75 (High)
Price
$2.06
Volume
1,349,123.966
Open
$2.08
Previous Close
$2.06
Daily Range
$2.03 - $2.10
52-Week Range
$1.77 - $5.81
GDRX News
How GoodRx Makes Money
Why GoodRx Surged Today
Why GoodRx Stock Soared Today
GDRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GoodRx
Industry
Health Care Technology
Sector
Health CareEmployees
697
CEO
Wendy Barnes, MBA
Website
www.goodrx.comHeadquarters
Santa Monica, CA 90404, US
GDRX Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
13%
Net Income Margin
4%
Return on Equity
5%
Return on Capital
9%
Return on Assets
2%
Earnings Yield
4.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$698.85M
Shares Outstanding
342.57M
Volume
1.35M
Short Interest
0.00%
Avg. Volume
3.17M
Financials (TTM)
Gross Profit
$654.13M
Operating Income
$106.97M
EBITDA
$184.36M
Operating Cash Flow
$167.90M
Capital Expenditure
$3.52M
Free Cash Flow
$164.38M
Cash & ST Invst.
$261.82M
Total Debt
$59.54M
GoodRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$194.78M
-1.9%
Gross Profit
$111.93M
-40.0%
Gross Margin
57.46%
N/A
Market Cap
$698.85M
N/A
Market Cap/Employee
$946.95K
N/A
Employees
738
N/A
Net Income
$5.42M
-19.5%
EBITDA
$50.05M
+19.6%
Quarterly Fundamentals
Net Cash
$202.28M
+312.8%
Accounts Receivable
$235.75M
+46.6%
Inventory
$0.00
N/A
Long Term Debt
$49.79M
-90.7%
Short Term Debt
$9.75M
-8.3%
Return on Assets
2.17%
N/A
Return on Invested Capital
9.24%
N/A
Free Cash Flow
$31.65M
+12.6%
Operating Cash Flow
$32.89M
-26.5%